Published: 02 December 2022
Over $1.7 billion has been invested into generative AI solutions by venture capital firms in the last five years, spawning multiple emerging use cases. Product leaders developing generative AI solutions should prioritize innovations around content, AI avatars and drug discovery.
Included in Full Research
Generative AI technology has attracted significant venture capital (VC) funding in the last three years, amounting to $1.7 billion across 255 deals.
AI-assisted drug discovery, AI code generation and AI avatars are the biggest VC funding segments in generative AI.
The generative AI market is buoyant, with over 100 small startups securing VC funding and the largest deals increasingly focused on later-stage startups that can deliver proven results and revenue growth.
The U.S. headquarters 40% of startups focusing on generative AI technology, and these attract nearly half of all VC funding, but significant innovation and startup activity is also happening
Clients can log in to view the entire